Methods of treating cancers comprising administering a fibroblast growth factor receptor 1 (FGFR1) extracellular domain (ECD) and/or an FGFR1 ECD fusion molecule are provided. Methods of treating cancers comprising administering a fibroblast growth factor receptor 1 (FGFR1) extracellular domain (ECD) and/or an FGFR1 ECD fusion molecule and at least one anti-angiogenic agent are provided.
申请公布号
AU2014268519(A1)
申请公布日期
2015.11.05
申请号
AU20140268519
申请日期
2014.05.22
申请人
FIVE PRIME THERAPEUTICS, INC.;GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO. 2) LIMITED
发明人
BELLOVIN, DAVID;BAKER, KEVIN;BRENNAN, THOMAS;PANDITE, ARUNDATHY NIRMALINI;MOOKERJEE, BIJOYESH;DEYOUNG, MAURICE P.;KUMAR, RAKESH
